首页> 外文OA文献 >The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production
【2h】

The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production

机译:对吸入可溶性蛋白抗原的天然免疫应答涉及主要的组织相容性复合物(MHC)I类限制的CD8 + T细胞介导的但MHC II类限制的CD4 + T细胞依赖性的免疫偏差,导致选择性抑制免疫球蛋白E的产生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The immunological basis for atopy is currently ascribed to an inherent bias in the CD4+ T cell response to nonreplicating antigens presented at mucosal surfaces, resulting in dominance of the T helper 2 (Th2) interleukin 4 (IL-4)-producing phenotype, which favors IgE production. In contrast, the "normal" response to such antigens involves a predominance of interferon gamma (IFN-gamma)-producing Th1 clones. This difference has been suggested to be the result of active selection in atopics for Th2 (and hence against Th1) clones at the time of initial antigen presentation. In the study below, we demonstrate that the natural immune response to inhaled protein antigens, particularly in animals expressing the low immunoglobulin E (IgE) responder phenotype, includes a major histocompatibility complex (MHC) class I-restricted CD8+ T cell component, the appearance of which is associated with active suppression of IgE antibody production. Thus, continued exposure of rats to aerosolized ovalbumin (OVA) antigen elicits a transient IgE response, that is terminated by the onset of a state of apparent "tolerance" to further challenge, and this tolerant state is transferable to naive animals with CD8+ T cells. Kinetic studies on in vitro T cell reactivity in these aerosol-exposed rats demonstrated biphasic CD4+ Th2 responses which terminated, together with IgE antibody production, and coincident with the appearance of MHC class I- restricted OVA-specific IFN-gamma-producing CD8+ T cells. However, the latter were not autonomous in vitro and required a source of exogenous IL-2 for initial activation, which in CD(8+)-enriched splenocyte cultures could be provided by small numbers of contaminating OVA- specific CD4+ T cells. This represents the first formal evidence for the induction of an MHC class I-restricted T cell response to natural mucosal exposure to an inert protein antigen, and is consistent with a growing literature demonstrating sensitization of MHC class I- restricted CD8+ T cells by deliberate immunization with soluble proteins. We suggest that crossregulation of MHC class II-restricted CD4+ T cells via cytokine signals generated in parallel CD8+ T cell responses represents a covert and potentially important selection pressure that can shape the nature of host responses to nonreplicating antigens presented at mucosal surfaces.
机译:特应性疾病的免疫学基础目前归因于CD4 + T细胞对粘膜表面非复制性抗原的内在偏倚,导致产生T辅助2(Th2)白介素4(IL-4)的表型占优势,这有利于IgE生产。相反,对此类抗原的“正常”应答涉及大量产生干扰素γ(IFN-γ)的Th1克隆。已经表明,这种差异是在初始抗原呈递时主动选择Th2(因此针对Th1)克隆的特应性的结果。在下面的研究中,我们证明了对吸入的蛋白抗原的天然免疫反应,特别是在表达低免疫球蛋白E(IgE)应答者表型的动物中,包括主要的组织相容性复合物(MHC)I类限制性CD8 + T细胞成分,其外观其中与主动抑制IgE抗体产生有关。因此,大鼠继续暴露于雾化的卵清蛋白(OVA)抗原会引发短暂的IgE反应,并通过出现明显的“耐受”状态终止以进一步攻击,并且这种耐受状态可转移至具有CD8 + T细胞的幼稚动物。在这些暴露于气溶胶​​的大鼠中进行体外T细胞反应性的动力学研究表明,双相CD4 + Th2反应终止,同时产生IgE抗体,并且与MHC I类限制的OVA特异性IFN-γ产生CD8 + T细胞同时出现。然而,后者在体外不是自主的,并且需要一个外源性的IL-2来进行初始激活,在富含CD(8+)的脾细胞培养物中,少量的OVA特异性CD4 + T细胞可提供污染。这代表了诱导MHC I类限制的T细胞对天然粘膜暴露于惰性蛋白抗原的反应的第一个正式证据,并且与越来越多的文献证明通过有意免疫对MHC I类限制的CD8 + T细胞致敏有关。与可溶性蛋白质。我们建议通过并行CD8 + T细胞反应中产生的细胞因子信号对MHC II类限制性CD4 + T细胞进行交叉调节代表了隐性和潜在的重要选择压力,可以决定宿主对粘膜表面非复制抗原反应的性质。

著录项

  • 作者

  • 作者单位
  • 年度 1993
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号